Former Microsoft CISO joins bio-electronics company board of directors

microscope science research
Credit: Pixabay

Charles McNerney, general manager of retail technology at Microsoft, and former CISO in its online services division, has been appointed to the board of directors of Nativis, Inc., a Seattle-based clinical stage bio-electronic company.

Founded in 2002, Nativis has invented and patented a technology that uses precisely targeted, ultra-low radio frequency energy (ulRFE) to specifically regulate metabolic pathways on the molecular and genetic levels — without chemicals, radiation or drugs – delivered via a simple-to-use non-invasive device called Nativis Voyager®. (Watch the video below for an explanation of the Nativis technology.)

Nativis’ initial focus is on the treatment of patients with brain cancer, and in the spring of 2015 Nativis partnered with Swedish Neuroscience Institute on a clinical trial to investigate the safety and efficacy of the Nativis Voyager RFE medical device in humans with recurrent glioblastoma multiforme, an aggressive brain tumor with a high rate of recurrence and a mortality rate of nearly 100 percent.

Writing about the clinical trial in a May, 2015 article in Science magazine, Derek Lowe said that "[he has] never been able to understand how the Nativis device can be more than an interesting-looking placebo."

Placebo or not, the technology continues to attract attention. In August of this year, Nativis entered into an agreement with a Japanese pharma company to conduct experiments and share results.

“Nativis’ innovative ulRFE technology and non-invasive approach to disease treatment presents a compelling opportunity in Glioblastoma Multiforme and potentially wider treatment applications," McNerney said in a statement. "I look forward to leveraging my expertise in building secure environments, systems development and testing, and manufacturing and supply chain management as Nativis moves forward with the clinical development and engineering of the Nativis Voyager® system as well as the development of new digital cognates from solvated molecules.”

McNerney has over 24 years of multi-disciplinary experience in the technology sector, ranging from physical and digital security protection to privacy and compliance. He has designed and implemented several innovative security solutions and has often been a keynote presenter at Microsoft’s key security briefings.

To comment on this article and other CSO content, visit our Facebook page or our Twitter stream.
Insider: Hacking the elections: myths and realities
Notice to our Readers
We're now using social media to take your comments and feedback. Learn more about this here.